← Back to all funds
Sofinnova Partners
Submit feedbackVenture CapitalHealthcareIndustrialTechnology
Pioneered European life sciences venture capital since 1972, focusing on company creation and early-stage investments in biotech and medtech. Notable exits include the acquisition of Ablynx by Sanofi and CoreValve by Medtronic.
€4B
AUM
7
Funds
80
Executives
11
Green Funds
Investment Profile
Investment Range
€100K - €30M
Focus
Early Stage
Geographies
Europe, USA
Assets (20 of 147)
11
Healthcare
7
Biopharmaceuticals
1
ICT
1
Medical Devices
| Asset | Status ↑ | Sector | HQ | Source | Entry Date |
|---|---|---|---|---|---|
| Current | Healthcare | Milan | Website | - | |
▶Alia Therapeutics | Current | Healthcare | Trento | Website | - |
▶BioClec | Current | Healthcare | Milan | Website | - |
▶BiovelocITA | Current | Healthcare | Milan | Website | - |
▶Borea Therapeutics | Current | Healthcare | Milan | Website | - |
▶Enthera Pharmaceuticals | Current | Healthcare | Milan | Website | - |
▶EOS | Current | Healthcare | Milan | Website | - |
| Current | Healthcare | Milan | Website | - | |
▶Heqet Therapeutics | Current | Biopharmaceuticals | Turin | Website | - |
▶Kither Biotech | Current | Biopharmaceuticals | Turin | Website | - |
▶Metis Precision Medicine | Current | Biopharmaceuticals | Turin | Website | - |
▶NanoPhoria | Current | Healthcare | Milan | Website | - |
Showing 1–12 of 20 assets
Page 1 of 2
Signals (2)
People
2026-02-18Sofinnova Partners portfolio company GenSight Biologics strengthens its regulatory team in the US and Europe with two senior hires
Source: Sofinnova Partners
Investment
2026-02-12European Life Sciences Coalition launched to strengthen Europe’s life sciences investment ecosystem
Source: Sofinnova Partners
Showing 1–2 of 2 signals